NR0B1 is a poor prognostic factor in hepatocellular carcinoma (HCC) that enhances sorafenib resistance by activating autophagy and inhibiting apoptosis, suggesting it as a detrimental influence on HCC treatment outcomes. This evidence concerns the gene NR0B1 and hepatocellular carcinoma.